Summary:
- A new study found that the diabetes drug semaglutide, which is used for weight loss, may also help reduce knee pain and inflammation in people with obesity.
- The study showed that participants who took semaglutide experienced a significant reduction in knee pain and improvements in physical function compared to those who took a placebo.
- The findings suggest that semaglutide could be a potential treatment option for people with obesity-related knee osteoarthritis, a common and debilitating condition.